Trial intelligence / Profile preview

Vitamin K on Knee Osteoarthritis Outcomes

NCT06385275Phase 2Active, not recruiting

Sponsor
Boston University
Start
Jun 2025
Primary completion
Sep 2026
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of phytomenadione, menaquinone-7 in knee osteoarthritis (OA), sponsored by Boston University. Started Jun 2025; status: active, not recruiting.

02

Drugs

phytomenadionemenaquinone-7
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT06385275.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06385275.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call